Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology
P Clemmensen, NP Dridi, L Holmvang - Cardiovascular drugs and therapy, 2013 - Springer
For several years, clopidogrel plus aspirin has been the dual antiplatelet therapy (DAPT) of
choice for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary …
choice for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary …
Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis
M Valgimigli, F Gragnano, M Branca… - JAMA …, 2024 - jamanetwork.com
Importance Among patients undergoing percutaneous coronary intervention (PCI), it
remains unclear whether the treatment efficacy of P2Y 12 inhibitor monotherapy after a short …
remains unclear whether the treatment efficacy of P2Y 12 inhibitor monotherapy after a short …
Prasugrel vs ticagrelor for DAPT in patients with ACS undergoing PCI: a systematic review and meta-analysis of randomized controlled trials
Introduction Dual antiplatelet therapy (DAPT) with a P2Y12 inhibitor added to aspirin is
considered the standard of care for patients with acute coronary syndrome (ACS) …
considered the standard of care for patients with acute coronary syndrome (ACS) …
Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention
Y Li, J Li, M Qiu, S Ma, K Na, X Li, Z Qi… - Catheterization and …, 2022 - Wiley Online Library
Objectives To evaluate the effectiveness and safety of ticagrelor versus clopidogrel in
patients with acute coronary syndromes (ACS) undergoing complex percutaneous coronary …
patients with acute coronary syndromes (ACS) undergoing complex percutaneous coronary …
Efficacy and safety of clopidogrel, prasugrel and ticagrelor in ACS patients treated with PCI: a propensity score analysis of the RENAMI and BleeMACS registries
M Peyracchia, A Saglietto, C Biole… - American Journal of …, 2020 - Springer
Introduction Real-life data comparing clopidogrel, prasugrel, and ticagrelor for unselected
patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome …
patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome …
Efficacy and safety of clopidogrel versus ticagrelor as part of dual antiplatelet therapy in acute coronary syndrome—a systematic review and meta-analysis
N Bergh, A Myredal, P Nivedahl… - Journal of …, 2022 - journals.lww.com
The efficacy and safety of clopidogrel compared with ticagrelor as part of dual antiplatelet
therapy in patients, and in older patients, with acute coronary syndrome is reviewed …
therapy in patients, and in older patients, with acute coronary syndrome is reviewed …
[HTML][HTML] Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
V Kumar, V Kumar, K Kumari, KK Talwar… - The Egyptian Heart …, 2018 - Elsevier
Introduction Dual antiplatelet treatment is recommended by current clinical practice
guidelines for patients undergoing PCI. The PLATO trial showed superiority of ticagrelor to …
guidelines for patients undergoing PCI. The PLATO trial showed superiority of ticagrelor to …
Oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention: Balancing efficacy and bleeding risk
SA Spinler - American Journal of Health-System Pharmacy, 2010 - academic.oup.com
Purpose The benefits and risk of bleeding associated with oral antiplatelet agents used for
acute coronary syndrome (ACS) or in patients who have undergone percutaneous coronary …
acute coronary syndrome (ACS) or in patients who have undergone percutaneous coronary …
[HTML][HTML] Comparison of clopidogrel with prasugrel and ticagrelor in patients with acute coronary syndrome: clinical outcomes from the national cardiovascular …
Background We aimed to compare the clinical outcomes of clopidogrel, prasugrel, and
ticagrelor in clinical practice using the National Cardiovascular Database ACTION …
ticagrelor in clinical practice using the National Cardiovascular Database ACTION …
Treatment pattern of contemporary dual antiplatelet therapies after acute coronary syndrome: a Swedish nationwide population-based cohort study
O Angerås, P Hasvold, M Thuresson… - Scandinavian …, 2016 - Taylor & Francis
Objectives New dual antiplatelet therapies (DAPTs) have been introduced in clinical practice
for patients with acute coronary syndrome (ACS). This nationwide study investigated DAPT …
for patients with acute coronary syndrome (ACS). This nationwide study investigated DAPT …